Confirming your payment

Skip to content

Competency-Based Questions (CBQ) · Question 41 of 80

A company tests a new liquid medicine by accelerated stability testing: samples are stored at raised temperatures and…

Question 415 marksHard

A company tests a new liquid medicine by accelerated stability testing: samples are stored at raised temperatures and the potency (% of the labelled amount of drug still present) is measured. The results are:

Time (days)0102030
Potency at 60 °C (%)10081.967.054.9
Time (days)0204060
Potency at 50 °C (%)10086.474.664.5

A medicine is acceptable only while its potency is at least 90%. Assume the activation energy does not change with temperature. (R=8.314 J K−1mol−1R = 8.314\ \text{J K}^{-1}\text{mol}^{-1})

(a) Show that the degradation is first order at 60 °C and find the rate constant k60k_{60}. [1]

(b) Find the rate constant k50k_{50} at 50 °C. [1]

(c) Calculate the activation energy of the degradation. [1]

(d) Calculate the rate constant at 25 °C and the shelf life (t90t_{90}, the time to fall to 90% potency) at 25 °C. [1]

(e) The marketing team wants to print "Expiry: 2 years from manufacture, store below 25 °C". Is this justified? What potency would remain after 2 years at 25 °C, and what storage instruction would you recommend instead? [1]